nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilotinib—MAPK8—skin epidermis—vitiligo	0.0349	0.0972	CbGeAlD
Nilotinib—PDGFRA—penis—vitiligo	0.0338	0.0942	CbGeAlD
Nilotinib—Pain of skin—Methoxsalen—vitiligo	0.0264	0.201	CcSEcCtD
Nilotinib—CA6—hair follicle—vitiligo	0.0179	0.0498	CbGeAlD
Nilotinib—MAPK8—neck—vitiligo	0.0167	0.0465	CbGeAlD
Nilotinib—MAPK14—hair follicle—vitiligo	0.0158	0.0441	CbGeAlD
Nilotinib—KIT—skin epidermis—vitiligo	0.0146	0.0406	CbGeAlD
Nilotinib—MAPK8—skin of body—vitiligo	0.0108	0.0301	CbGeAlD
Nilotinib—MAPK14—neck—vitiligo	0.0106	0.0296	CbGeAlD
Nilotinib—Skin hyperpigmentation—Methoxsalen—vitiligo	0.0105	0.0798	CcSEcCtD
Nilotinib—Folliculitis—Methoxsalen—vitiligo	0.0099	0.0755	CcSEcCtD
Nilotinib—MAPK11—thyroid gland—vitiligo	0.00887	0.0247	CbGeAlD
Nilotinib—CDC42BPB—thyroid gland—vitiligo	0.00879	0.0245	CbGeAlD
Nilotinib—Blister—Methoxsalen—vitiligo	0.00863	0.0659	CcSEcCtD
Nilotinib—EPHA3—thyroid gland—vitiligo	0.00834	0.0232	CbGeAlD
Nilotinib—MAPK8—thyroid gland—vitiligo	0.00795	0.0222	CbGeAlD
Nilotinib—MAP4K1—thyroid gland—vitiligo	0.00723	0.0201	CbGeAlD
Nilotinib—KIT—neck—vitiligo	0.00697	0.0194	CbGeAlD
Nilotinib—TIE1—thyroid gland—vitiligo	0.00689	0.0192	CbGeAlD
Nilotinib—MAPK14—skin of body—vitiligo	0.00687	0.0191	CbGeAlD
Nilotinib—PDGFRB—neck—vitiligo	0.00681	0.019	CbGeAlD
Nilotinib—Herpes simplex—Methoxsalen—vitiligo	0.00675	0.0515	CcSEcCtD
Nilotinib—BRAF—thyroid gland—vitiligo	0.00661	0.0184	CbGeAlD
Nilotinib—CA2—hair follicle—vitiligo	0.00616	0.0172	CbGeAlD
Nilotinib—HCK—thyroid gland—vitiligo	0.00603	0.0168	CbGeAlD
Nilotinib—ABL2—thyroid gland—vitiligo	0.00599	0.0167	CbGeAlD
Nilotinib—EPHB6—skin of body—vitiligo	0.00595	0.0166	CbGeAlD
Nilotinib—Skin exfoliation—Methoxsalen—vitiligo	0.00594	0.0453	CcSEcCtD
Nilotinib—EPHA4—thyroid gland—vitiligo	0.00548	0.0153	CbGeAlD
Nilotinib—CA3—thyroid gland—vitiligo	0.00541	0.0151	CbGeAlD
Nilotinib—MAPK14—thyroid gland—vitiligo	0.00505	0.0141	CbGeAlD
Nilotinib—LCK—thyroid gland—vitiligo	0.00503	0.014	CbGeAlD
Nilotinib—FGR—thyroid gland—vitiligo	0.00503	0.014	CbGeAlD
Nilotinib—CA4—neck—vitiligo	0.00498	0.0139	CbGeAlD
Nilotinib—CSF1R—skin of body—vitiligo	0.00497	0.0138	CbGeAlD
Nilotinib—EPHB4—thyroid gland—vitiligo	0.00479	0.0133	CbGeAlD
Nilotinib—Dermatitis bullous—Methoxsalen—vitiligo	0.00473	0.0361	CcSEcCtD
Nilotinib—EPHA2—thyroid gland—vitiligo	0.0047	0.0131	CbGeAlD
Nilotinib—TEK—thyroid gland—vitiligo	0.00458	0.0128	CbGeAlD
Nilotinib—KIT—skin of body—vitiligo	0.00451	0.0126	CbGeAlD
Nilotinib—PDGFRB—skin of body—vitiligo	0.00441	0.0123	CbGeAlD
Nilotinib—EPHB6—thyroid gland—vitiligo	0.00438	0.0122	CbGeAlD
Nilotinib—PDGFRA—thyroid gland—vitiligo	0.00415	0.0116	CbGeAlD
Nilotinib—Dry skin—Methoxsalen—vitiligo	0.00414	0.0316	CcSEcCtD
Nilotinib—CA2—neck—vitiligo	0.00413	0.0115	CbGeAlD
Nilotinib—ABL1—skin of body—vitiligo	0.00393	0.0109	CbGeAlD
Nilotinib—MAP2K5—thyroid gland—vitiligo	0.00374	0.0104	CbGeAlD
Nilotinib—CSF1R—thyroid gland—vitiligo	0.00365	0.0102	CbGeAlD
Nilotinib—Photosensitivity reaction—Methoxsalen—vitiligo	0.00356	0.0272	CcSEcCtD
Nilotinib—KIT—thyroid gland—vitiligo	0.00332	0.00924	CbGeAlD
Nilotinib—PDGFRB—thyroid gland—vitiligo	0.00324	0.00903	CbGeAlD
Nilotinib—ABL1—thyroid gland—vitiligo	0.00289	0.00805	CbGeAlD
Nilotinib—Arrhythmia—Methoxsalen—vitiligo	0.00279	0.0213	CcSEcCtD
Nilotinib—Erythema—Methoxsalen—vitiligo	0.00272	0.0208	CcSEcCtD
Nilotinib—CA2—skin of body—vitiligo	0.00267	0.00745	CbGeAlD
Nilotinib—Dysgeusia—Methoxsalen—vitiligo	0.00266	0.0203	CcSEcCtD
Nilotinib—Muscle spasms—Methoxsalen—vitiligo	0.00262	0.02	CcSEcCtD
Nilotinib—Ill-defined disorder—Methoxsalen—vitiligo	0.00252	0.0193	CcSEcCtD
Nilotinib—Malaise—Methoxsalen—vitiligo	0.00245	0.0187	CcSEcCtD
Nilotinib—Vertigo—Methoxsalen—vitiligo	0.00244	0.0186	CcSEcCtD
Nilotinib—CA4—thyroid gland—vitiligo	0.00237	0.00661	CbGeAlD
Nilotinib—Discomfort—Methoxsalen—vitiligo	0.00229	0.0175	CcSEcCtD
Nilotinib—CYP2B6—skin of body—vitiligo	0.00229	0.00637	CbGeAlD
Nilotinib—Oedema—Methoxsalen—vitiligo	0.00222	0.0169	CcSEcCtD
Nilotinib—Infection—Methoxsalen—vitiligo	0.00221	0.0168	CcSEcCtD
Nilotinib—Skin disorder—Methoxsalen—vitiligo	0.00216	0.0164	CcSEcCtD
Nilotinib—Hypotension—Methoxsalen—vitiligo	0.00207	0.0158	CcSEcCtD
Nilotinib—Insomnia—Methoxsalen—vitiligo	0.00201	0.0153	CcSEcCtD
Nilotinib—CA2—thyroid gland—vitiligo	0.00197	0.00548	CbGeAlD
Nilotinib—Dyspepsia—Methoxsalen—vitiligo	0.00195	0.0149	CcSEcCtD
Nilotinib—Gastrointestinal disorder—Methoxsalen—vitiligo	0.00192	0.0146	CcSEcCtD
Nilotinib—Feeling abnormal—Methoxsalen—vitiligo	0.00183	0.014	CcSEcCtD
Nilotinib—ABCG2—thyroid gland—vitiligo	0.00182	0.00508	CbGeAlD
Nilotinib—Urticaria—Methoxsalen—vitiligo	0.00176	0.0135	CcSEcCtD
Nilotinib—Body temperature increased—Methoxsalen—vitiligo	0.00176	0.0134	CcSEcCtD
Nilotinib—Hypersensitivity—Methoxsalen—vitiligo	0.00164	0.0125	CcSEcCtD
Nilotinib—Pruritus—Methoxsalen—vitiligo	0.00157	0.012	CcSEcCtD
Nilotinib—Dizziness—Methoxsalen—vitiligo	0.00147	0.0112	CcSEcCtD
Nilotinib—Rash—Methoxsalen—vitiligo	0.0014	0.0107	CcSEcCtD
Nilotinib—Dermatitis—Methoxsalen—vitiligo	0.0014	0.0107	CcSEcCtD
Nilotinib—Headache—Methoxsalen—vitiligo	0.00139	0.0106	CcSEcCtD
Nilotinib—Nausea—Methoxsalen—vitiligo	0.00132	0.0101	CcSEcCtD
Nilotinib—ABCB1—thyroid gland—vitiligo	0.000898	0.0025	CbGeAlD
Nilotinib—HCK—Immune System—CD44—vitiligo	0.00023	0.000452	CbGpPWpGaD
Nilotinib—LCK—Innate Immune System—CCR6—vitiligo	0.000229	0.00045	CbGpPWpGaD
Nilotinib—LCK—Innate Immune System—IFIH1—vitiligo	0.000229	0.00045	CbGpPWpGaD
Nilotinib—LCK—NGF signalling via TRKA from the plasma membrane—CD80—vitiligo	0.000229	0.000449	CbGpPWpGaD
Nilotinib—CA14—Metabolism—CAT—vitiligo	0.000227	0.000446	CbGpPWpGaD
Nilotinib—HCK—Immune System—CTLA4—vitiligo	0.000227	0.000445	CbGpPWpGaD
Nilotinib—CA4—Metabolism—GSTT1—vitiligo	0.000227	0.000444	CbGpPWpGaD
Nilotinib—MAPK14—Hemostasis—CD44—vitiligo	0.000226	0.000444	CbGpPWpGaD
Nilotinib—HCK—Innate Immune System—CD80—vitiligo	0.000226	0.000442	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—MC1R—vitiligo	0.000223	0.000438	CbGpPWpGaD
Nilotinib—CA6—Metabolism—CAT—vitiligo	0.000222	0.000435	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling by NGF—CD80—vitiligo	0.00022	0.000431	CbGpPWpGaD
Nilotinib—CA2—Metabolism—GSTT1—vitiligo	0.000217	0.000426	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—IFIH1—vitiligo	0.000216	0.000424	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—CCR6—vitiligo	0.000216	0.000424	CbGpPWpGaD
Nilotinib—LCK—Cytokine Signaling in Immune system—IL2RA—vitiligo	0.000215	0.000421	CbGpPWpGaD
Nilotinib—CA14—Metabolism—GSTM1—vitiligo	0.000215	0.000421	CbGpPWpGaD
Nilotinib—CYP2C8—Biological oxidations—GSTM1—vitiligo	0.000214	0.000419	CbGpPWpGaD
Nilotinib—HCK—Disease—CD44—vitiligo	0.000213	0.000417	CbGpPWpGaD
Nilotinib—CYP2C8—Metapathway biotransformation—GSTM1—vitiligo	0.000211	0.000414	CbGpPWpGaD
Nilotinib—CA6—Metabolism—GSTM1—vitiligo	0.000209	0.00041	CbGpPWpGaD
Nilotinib—BLK—Immune System—CD44—vitiligo	0.000209	0.000409	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—CD44—vitiligo	0.000209	0.000409	CbGpPWpGaD
Nilotinib—CA1—Metabolism—GSTT1—vitiligo	0.000208	0.000408	CbGpPWpGaD
Nilotinib—FGR—Immune System—CD44—vitiligo	0.000208	0.000408	CbGpPWpGaD
Nilotinib—PDGFRB—Adaptive Immune System—CTLA4—vitiligo	0.000208	0.000408	CbGpPWpGaD
Nilotinib—CA7—Metabolism—CAT—vitiligo	0.000207	0.000406	CbGpPWpGaD
Nilotinib—BLK—Immune System—CTLA4—vitiligo	0.000206	0.000404	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—CTLA4—vitiligo	0.000206	0.000404	CbGpPWpGaD
Nilotinib—FGR—Immune System—CTLA4—vitiligo	0.000205	0.000402	CbGpPWpGaD
Nilotinib—MAPK8—Innate Immune System—CD80—vitiligo	0.000204	0.000401	CbGpPWpGaD
Nilotinib—MAPK14—Signaling by NGF—CD80—vitiligo	0.000204	0.0004	CbGpPWpGaD
Nilotinib—FGR—Innate Immune System—CD80—vitiligo	0.000204	0.000399	CbGpPWpGaD
Nilotinib—LYN—Adaptive Immune System—CTLA4—vitiligo	0.000204	0.000399	CbGpPWpGaD
Nilotinib—BLK—Adaptive Immune System—CD80—vitiligo	0.000196	0.000385	CbGpPWpGaD
Nilotinib—LCK—Hemostasis—CD44—vitiligo	0.000196	0.000384	CbGpPWpGaD
Nilotinib—CA7—Metabolism—GSTM1—vitiligo	0.000195	0.000383	CbGpPWpGaD
Nilotinib—KIT—Immune System—CCR6—vitiligo	0.000195	0.000383	CbGpPWpGaD
Nilotinib—KIT—Immune System—IFIH1—vitiligo	0.000195	0.000383	CbGpPWpGaD
Nilotinib—CA12—Metabolism—CAT—vitiligo	0.000192	0.000376	CbGpPWpGaD
Nilotinib—CA4—Metabolism—CD44—vitiligo	0.000188	0.000369	CbGpPWpGaD
Nilotinib—KIT—Adaptive Immune System—CD8A—vitiligo	0.000187	0.000368	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—MC1R—vitiligo	0.000187	0.000367	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—MC1R—vitiligo	0.000186	0.000364	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—IFIH1—vitiligo	0.000185	0.000362	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—CCR6—vitiligo	0.000185	0.000362	CbGpPWpGaD
Nilotinib—CA9—Metabolism—GSTT1—vitiligo	0.000183	0.000359	CbGpPWpGaD
Nilotinib—CA12—Metabolism—GSTM1—vitiligo	0.000181	0.000355	CbGpPWpGaD
Nilotinib—CA2—Metabolism—CD44—vitiligo	0.000181	0.000354	CbGpPWpGaD
Nilotinib—CYP3A4—Biological oxidations—GSTT1—vitiligo	0.00018	0.000353	CbGpPWpGaD
Nilotinib—PDGFRA—Adaptive Immune System—CD8A—vitiligo	0.000177	0.000348	CbGpPWpGaD
Nilotinib—LCK—Signaling by NGF—CD80—vitiligo	0.000176	0.000346	CbGpPWpGaD
Nilotinib—CYP2D6—Biological oxidations—GSTM1—vitiligo	0.000176	0.000344	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—CCR6—vitiligo	0.000176	0.000344	CbGpPWpGaD
Nilotinib—HCK—Immune System—CD8A—vitiligo	0.000175	0.000342	CbGpPWpGaD
Nilotinib—CYP2C9—Biological oxidations—GSTM1—vitiligo	0.000174	0.000341	CbGpPWpGaD
Nilotinib—CYP2D6—Metapathway biotransformation—GSTM1—vitiligo	0.000173	0.00034	CbGpPWpGaD
Nilotinib—CA1—Metabolism—CD44—vitiligo	0.000173	0.000339	CbGpPWpGaD
Nilotinib—CYP2C9—Metapathway biotransformation—GSTM1—vitiligo	0.000172	0.000337	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—MC1R—vitiligo	0.000169	0.000331	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—CCR6—vitiligo	0.000167	0.000327	CbGpPWpGaD
Nilotinib—LCK—Adaptive Immune System—CTLA4—vitiligo	0.000167	0.000327	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—SH2B3—vitiligo	0.000166	0.000326	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—CD44—vitiligo	0.000166	0.000326	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—IFIH1—vitiligo	0.000166	0.000326	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—CCR6—vitiligo	0.000166	0.000326	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—GZMB—vitiligo	0.000165	0.000324	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—CTLA4—vitiligo	0.000164	0.000322	CbGpPWpGaD
Nilotinib—LYN—Hemostasis—IL2RA—vitiligo	0.000163	0.00032	CbGpPWpGaD
Nilotinib—LYN—Immune System—IFIH1—vitiligo	0.000163	0.000319	CbGpPWpGaD
Nilotinib—LYN—Immune System—CCR6—vitiligo	0.000163	0.000319	CbGpPWpGaD
Nilotinib—MAPK11—Innate Immune System—CD80—vitiligo	0.000163	0.000319	CbGpPWpGaD
Nilotinib—ABL1—Hemostasis—IL2RA—vitiligo	0.000162	0.000319	CbGpPWpGaD
Nilotinib—ABL1—Immune System—IFIH1—vitiligo	0.000162	0.000318	CbGpPWpGaD
Nilotinib—ABL1—Immune System—CCR6—vitiligo	0.000162	0.000318	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—MC1R—vitiligo	0.00016	0.000313	CbGpPWpGaD
Nilotinib—PDGFRB—Adaptive Immune System—CD8A—vitiligo	0.00016	0.000313	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—CD8A—vitiligo	0.000158	0.00031	CbGpPWpGaD
Nilotinib—BLK—Immune System—CD8A—vitiligo	0.000158	0.00031	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—SH2B3—vitiligo	0.000158	0.00031	CbGpPWpGaD
Nilotinib—FGR—Immune System—CD8A—vitiligo	0.000158	0.000309	CbGpPWpGaD
Nilotinib—HCK—Immune System—IL2RA—vitiligo	0.000157	0.000309	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—GZMB—vitiligo	0.000157	0.000308	CbGpPWpGaD
Nilotinib—LYN—Adaptive Immune System—CD8A—vitiligo	0.000157	0.000307	CbGpPWpGaD
Nilotinib—MAPK14—Hemostasis—IL2RA—vitiligo	0.000155	0.000303	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—IFIH1—vitiligo	0.000154	0.000303	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—CCR6—vitiligo	0.000154	0.000303	CbGpPWpGaD
Nilotinib—CA4—Metabolism—CAT—vitiligo	0.000153	0.0003	CbGpPWpGaD
Nilotinib—BRAF—Disease—CD44—vitiligo	0.000152	0.000298	CbGpPWpGaD
Nilotinib—CA9—Metabolism—CD44—vitiligo	0.000152	0.000298	CbGpPWpGaD
Nilotinib—KIT—Immune System—CD44—vitiligo	0.00015	0.000294	CbGpPWpGaD
Nilotinib—KIT—Immune System—CTLA4—vitiligo	0.000148	0.00029	CbGpPWpGaD
Nilotinib—KIT—Innate Immune System—CD80—vitiligo	0.000147	0.000288	CbGpPWpGaD
Nilotinib—CA2—Metabolism—CAT—vitiligo	0.000147	0.000287	CbGpPWpGaD
Nilotinib—CA4—Metabolism—GSTM1—vitiligo	0.000144	0.000283	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—MC1R—vitiligo	0.000144	0.000282	CbGpPWpGaD
Nilotinib—BLK—Immune System—IL2RA—vitiligo	0.000143	0.00028	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—IL2RA—vitiligo	0.000143	0.00028	CbGpPWpGaD
Nilotinib—FGR—Immune System—IL2RA—vitiligo	0.000142	0.000279	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—CD44—vitiligo	0.000142	0.000278	CbGpPWpGaD
Nilotinib—KIT—Adaptive Immune System—CD80—vitiligo	0.000141	0.000277	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—MC1R—vitiligo	0.000141	0.000277	CbGpPWpGaD
Nilotinib—CA1—Metabolism—CAT—vitiligo	0.00014	0.000275	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—CTLA4—vitiligo	0.00014	0.000274	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—CCR6—vitiligo	0.00014	0.000274	CbGpPWpGaD
Nilotinib—PDGFRA—Innate Immune System—CD80—vitiligo	0.000139	0.000273	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—CCR6—vitiligo	0.000139	0.000272	CbGpPWpGaD
Nilotinib—KIT—Disease—CD44—vitiligo	0.000139	0.000272	CbGpPWpGaD
Nilotinib—CA2—Metabolism—GSTM1—vitiligo	0.000138	0.000271	CbGpPWpGaD
Nilotinib—LCK—Hemostasis—IL2RA—vitiligo	0.000134	0.000262	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—MC1R—vitiligo	0.000134	0.000262	CbGpPWpGaD
Nilotinib—LCK—Immune System—IFIH1—vitiligo	0.000134	0.000262	CbGpPWpGaD
Nilotinib—LCK—Immune System—CCR6—vitiligo	0.000134	0.000262	CbGpPWpGaD
Nilotinib—PDGFRA—Adaptive Immune System—CD80—vitiligo	0.000133	0.000262	CbGpPWpGaD
Nilotinib—CA1—Metabolism—GSTM1—vitiligo	0.000133	0.00026	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—SH2B3—vitiligo	0.000133	0.00026	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—GZMB—vitiligo	0.000132	0.000258	CbGpPWpGaD
Nilotinib—HCK—Immune System—CD80—vitiligo	0.000131	0.000258	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—SH2B3—vitiligo	0.000131	0.000258	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—CD44—vitiligo	0.000131	0.000257	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—GZMB—vitiligo	0.000131	0.000256	CbGpPWpGaD
Nilotinib—LCK—Adaptive Immune System—CD8A—vitiligo	0.000128	0.000252	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—CD44—vitiligo	0.000128	0.000251	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—CCR6—vitiligo	0.000126	0.000247	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—CD8A—vitiligo	0.000126	0.000247	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—CTLA4—vitiligo	0.000126	0.000247	CbGpPWpGaD
Nilotinib—LYN—Immune System—CD44—vitiligo	0.000125	0.000246	CbGpPWpGaD
Nilotinib—PDGFRB—Innate Immune System—CD80—vitiligo	0.000125	0.000246	CbGpPWpGaD
Nilotinib—ABL1—Immune System—CD44—vitiligo	0.000125	0.000244	CbGpPWpGaD
Nilotinib—CA9—Metabolism—CAT—vitiligo	0.000123	0.000242	CbGpPWpGaD
Nilotinib—LYN—Immune System—CTLA4—vitiligo	0.000123	0.000242	CbGpPWpGaD
Nilotinib—ABL1—Immune System—CTLA4—vitiligo	0.000123	0.000241	CbGpPWpGaD
Nilotinib—LYN—Innate Immune System—CD80—vitiligo	0.000123	0.00024	CbGpPWpGaD
Nilotinib—ABL1—Innate Immune System—CD80—vitiligo	0.000122	0.000239	CbGpPWpGaD
Nilotinib—HCK—Disease—CD80—vitiligo	0.000121	0.000238	CbGpPWpGaD
Nilotinib—PDGFRB—Adaptive Immune System—CD80—vitiligo	0.00012	0.000236	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—SH2B3—vitiligo	0.00012	0.000234	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—CCR6—vitiligo	0.000119	0.000234	CbGpPWpGaD
Nilotinib—BLK—Immune System—CD80—vitiligo	0.000119	0.000233	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—CD80—vitiligo	0.000119	0.000233	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—GZMB—vitiligo	0.000119	0.000233	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—CD44—vitiligo	0.000119	0.000233	CbGpPWpGaD
Nilotinib—FGR—Immune System—CD80—vitiligo	0.000119	0.000233	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—CD44—vitiligo	0.000118	0.000232	CbGpPWpGaD
Nilotinib—LYN—Adaptive Immune System—CD80—vitiligo	0.000118	0.000231	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—CTLA4—vitiligo	0.000117	0.000229	CbGpPWpGaD
Nilotinib—CA9—Metabolism—GSTM1—vitiligo	0.000117	0.000229	CbGpPWpGaD
Nilotinib—MAPK14—Innate Immune System—CD80—vitiligo	0.000116	0.000228	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—MC1R—vitiligo	0.000116	0.000227	CbGpPWpGaD
Nilotinib—CYP3A4—Biological oxidations—GSTM1—vitiligo	0.000115	0.000225	CbGpPWpGaD
Nilotinib—KIT—Immune System—CD8A—vitiligo	0.000114	0.000223	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—IL2RA—vitiligo	0.000114	0.000223	CbGpPWpGaD
Nilotinib—CYP3A4—Metapathway biotransformation—GSTM1—vitiligo	0.000113	0.000222	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—SH2B3—vitiligo	0.000113	0.000222	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—GZMB—vitiligo	0.000112	0.000221	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—GSTT1—vitiligo	0.000109	0.000214	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—CD8A—vitiligo	0.000108	0.000211	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—CCR6—vitiligo	0.000108	0.000211	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—CCR6—vitiligo	0.000105	0.000207	CbGpPWpGaD
Nilotinib—LCK—Immune System—CD44—vitiligo	0.000103	0.000201	CbGpPWpGaD
Nilotinib—KIT—Immune System—IL2RA—vitiligo	0.000102	0.000201	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—SH2B3—vitiligo	0.000102	0.0002	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—GZMB—vitiligo	0.000101	0.000199	CbGpPWpGaD
Nilotinib—LCK—Immune System—CTLA4—vitiligo	0.000101	0.000198	CbGpPWpGaD
Nilotinib—LCK—Innate Immune System—CD80—vitiligo	0.000101	0.000197	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—CCR6—vitiligo	9.98e-05	0.000196	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—SH2B3—vitiligo	9.98e-05	0.000196	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—GZMB—vitiligo	9.92e-05	0.000195	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—IL2RA—vitiligo	9.7e-05	0.00019	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—CD8A—vitiligo	9.7e-05	0.00019	CbGpPWpGaD
Nilotinib—LCK—Adaptive Immune System—CD80—vitiligo	9.65e-05	0.000189	CbGpPWpGaD
Nilotinib—LYN—Immune System—CD8A—vitiligo	9.49e-05	0.000186	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—CD80—vitiligo	9.49e-05	0.000186	CbGpPWpGaD
Nilotinib—LCK—Disease—CD44—vitiligo	9.48e-05	0.000186	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—SH2B3—vitiligo	9.46e-05	0.000186	CbGpPWpGaD
Nilotinib—ABL1—Immune System—CD8A—vitiligo	9.45e-05	0.000185	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—GZMB—vitiligo	9.41e-05	0.000184	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—GSTT1—vitiligo	9.25e-05	0.000181	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—IL2RA—vitiligo	9.22e-05	0.000181	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—CD44—vitiligo	9.06e-05	0.000178	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—CD8A—vitiligo	9e-05	0.000176	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—IL2RA—vitiligo	8.77e-05	0.000172	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—IL2RA—vitiligo	8.74e-05	0.000171	CbGpPWpGaD
Nilotinib—BRAF—Disease—CD80—vitiligo	8.68e-05	0.00017	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—CCR6—vitiligo	8.63e-05	0.000169	CbGpPWpGaD
Nilotinib—LYN—Immune System—IL2RA—vitiligo	8.56e-05	0.000168	CbGpPWpGaD
Nilotinib—KIT—Immune System—CD80—vitiligo	8.55e-05	0.000168	CbGpPWpGaD
Nilotinib—ABL1—Immune System—IL2RA—vitiligo	8.52e-05	0.000167	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—SH2B3—vitiligo	8.18e-05	0.00016	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—GZMB—vitiligo	8.13e-05	0.000159	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—IL2RA—vitiligo	8.11e-05	0.000159	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—CD80—vitiligo	8.1e-05	0.000159	CbGpPWpGaD
Nilotinib—KIT—Disease—CD80—vitiligo	7.9e-05	0.000155	CbGpPWpGaD
Nilotinib—LCK—Immune System—CD8A—vitiligo	7.78e-05	0.000153	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—CD80—vitiligo	7.7e-05	0.000151	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—CD44—vitiligo	7.69e-05	0.000151	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—CD80—vitiligo	7.48e-05	0.000147	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—CAT—vitiligo	7.36e-05	0.000144	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—IL2RA—vitiligo	7.35e-05	0.000144	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—CD80—vitiligo	7.32e-05	0.000144	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—CD80—vitiligo	7.29e-05	0.000143	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—IL2RA—vitiligo	7.28e-05	0.000143	CbGpPWpGaD
Nilotinib—LYN—Immune System—CD80—vitiligo	7.14e-05	0.00014	CbGpPWpGaD
Nilotinib—ABL1—Immune System—CD80—vitiligo	7.11e-05	0.000139	CbGpPWpGaD
Nilotinib—LCK—Immune System—IL2RA—vitiligo	7.01e-05	0.000138	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—GSTM1—vitiligo	6.95e-05	0.000136	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—GSTT1—vitiligo	6.78e-05	0.000133	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—CD80—vitiligo	6.77e-05	0.000133	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—CD80—vitiligo	6.73e-05	0.000132	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—IL2RA—vitiligo	6.63e-05	0.00013	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—IL2RA—vitiligo	6.27e-05	0.000123	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—CAT—vitiligo	6.24e-05	0.000122	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—CD80—vitiligo	6.13e-05	0.00012	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—CD80—vitiligo	6.08e-05	0.000119	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—GSTM1—vitiligo	5.89e-05	0.000116	CbGpPWpGaD
Nilotinib—LCK—Immune System—CD80—vitiligo	5.85e-05	0.000115	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—GSTT1—vitiligo	5.74e-05	0.000113	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—IL2RA—vitiligo	5.65e-05	0.000111	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—CD44—vitiligo	5.64e-05	0.000111	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—IL2RA—vitiligo	5.53e-05	0.000108	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—CD80—vitiligo	5.53e-05	0.000108	CbGpPWpGaD
Nilotinib—LCK—Disease—CD80—vitiligo	5.4e-05	0.000106	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—IL2RA—vitiligo	5.24e-05	0.000103	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—CD80—vitiligo	5.23e-05	0.000103	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—GSTT1—vitiligo	5e-05	9.81e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—CD44—vitiligo	4.77e-05	9.36e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—CD80—vitiligo	4.72e-05	9.25e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—GSTT1—vitiligo	4.71e-05	9.25e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—GSTT1—vitiligo	4.67e-05	9.17e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—CD80—vitiligo	4.62e-05	9.05e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—CAT—vitiligo	4.58e-05	8.97e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—IL2RA—vitiligo	4.53e-05	8.89e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—CD80—vitiligo	4.38e-05	8.58e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—GSTM1—vitiligo	4.32e-05	8.47e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—CD44—vitiligo	4.16e-05	8.15e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—CD44—vitiligo	3.92e-05	7.68e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—CD44—vitiligo	3.88e-05	7.62e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—CAT—vitiligo	3.87e-05	7.6e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—CD80—vitiligo	3.78e-05	7.42e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—GSTM1—vitiligo	3.66e-05	7.17e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—CAT—vitiligo	3.37e-05	6.62e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—GSTM1—vitiligo	3.19e-05	6.25e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—CAT—vitiligo	3.18e-05	6.24e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—CAT—vitiligo	3.15e-05	6.18e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—GSTT1—vitiligo	3.08e-05	6.04e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—GSTM1—vitiligo	3e-05	5.89e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—GSTM1—vitiligo	2.98e-05	5.84e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CD44—vitiligo	2.56e-05	5.02e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CAT—vitiligo	2.08e-05	4.08e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—GSTM1—vitiligo	1.96e-05	3.85e-05	CbGpPWpGaD
